https://www.selleckchem.com/products/az628.html
4 (6.4-8.7) versus 9.5 (8.1-11.; adjusted hazard ratio (HR) (95% CI) = 0.81 (0.60-1.09), P = 0.17. Patients exposed to SPS did not experience a higher rate of adverse GI events in the year after SPS initiation versus the year before SPS initiation; P-value for parallel trend = 0.87. Patients on-CPS also did not show an increased risk of adverse GI events versus off-CPS IR (per 1000py) = 8.6 (5.1-11.9) versus 7.8 (5.1-11.9); adjusted HR (95% CI) = 0.76 (0.31-1.8, P = 0.52. The rates of adverse GI events in the periods on and off exposu
Like
Comment
Share
